SEC Form 4 · accession 0001181431-15-001001
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen A. Fienberg
Officer — VP of Business Development
Period of report
Jan 14, 2015
Accepted (ET)
Jan 16, 2015 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 14, 2015 | S | 5,000 | $19.00 | D | 270,000 | D | |
| Common StockF2 | holding | — | — | — | 208,023 | I | Held by J.D.F. Holdings Ltd. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2014. The proceeds of this sale will be used primarily to cover the reporting person's tax liability arising from option exercises.
- F2Dr. Fienberg holds a 20% ownership interest in J.D.F. Holdings Ltd. and may be deemed to beneficially own the securities held by J.D.F. Holdings Ltd. Dr. Fienberg disclaims beneficial ownership of the securities held by J.D.F. Holdings Ltd. except to the extent of his pecuniary interest therein.